Trine Folseraas

Trine Folseraas serves as Associate Professor at the Department of Transplantation, Faculty of Medicine, University of Oslo, with clinical affiliation at Oslo University Hospital (OUS Rikshospitalet). Her research centers on primary sclerosing cholangitis (PSC), cholangiocarcinoma, and liver transplantation outcomes. She maintains active roles in the Clinical Liver Research Center and NoPSC initiatives.

Her research interests span genetic epidemiology of autoimmune liver diseases, cancer risk stratification in PSC, and mechanistic studies of biliary pathogenesis. Recent work integrates multi-omics approaches including genomics, metabolomics, and transcriptomics to identify biomarkers and therapeutic targets. Her publications reveal strong focus on immune dysregulation in PSC, bile composition analysis, and cross-border comparative studies between Norwegian and international patient populations.

Analysis of her 15 most recent publications (2021-2025) shows consistent output in high-impact hepatology journals with emphasis on translational research connecting molecular mechanisms to clinical outcomes. Key trends include development of liquid biopsy biomarkers for cholangiocarcinoma detection, investigation of vitamin metabolism in liver disease, and application of advanced computational methods to imaging and genomic data.

Dr. Folseraas participates in major international collaborations including the European Network for the Study of Cholangiocarcinoma (ENS-CCA) and multi-center clinical trials like TESLA. Her work demonstrates consistent funding through participation in large-scale research consortia focused on rare liver diseases and cancer outcomes.

Her laboratory work, conducted through the Clinical Liver Research Center, focuses on molecular characterization of PSC progression and cholangiocarcinoma development. The research environment emphasizes translational approaches bridging basic science discoveries with clinical applications in hepatology and transplantation medicine.